– Interview with Dirk Hockemeyer, Ph.D., Postdoctoral Researcher, Whitehead Institute for Biomedical Research, Cambridge, MA

Previous articleRoche Pays PTC $12M Up Front in CNS Drug Discovery Collaboration
Next articleScientists Use C. Crescentus to Make Proteins